Bedrocan Cannabis is Drug Discovery in Canada that focus on healthcare professionals business. Founded in 2003. They cover business area such as producer, distributor, medicinal cannabis, drug manufacturing, multiple variety, pharmaceutical-grade cannabi, patient, healthcare professional, seven country, Canada, pharmaceutical business, standardised medicinal-grade cannabis, a number, international government.
2003
( 21 years old in 2024 )
Healthcare Professionals
-
250A Eglinton Avenue East
PO BOX 89589
Toronto, Ontario M4P 3E1
Canada
Private
producerdistributormedicinal cannabisdrug manufacturingmultiple varietypharmaceutical-grade cannabipatienthealthcare professionalseven countryCanadapharmaceutical businessstandardised medicinal-grade cannabisa numberinternational government
* We use standard office opening hours in near Bedrocan Cannabis's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Bedrocan Cannabis is Drug Discovery business from Canada that founded in 2003 (21 years old in 2024), Bedrocan Cannabis business is focusing on Healthcare Professionals.
Bedrocan Cannabis headquarter office and corporate office address is located in 250A Eglinton Avenue East PO BOX 89589 Toronto, Ontario M4P 3E1 Canada.
Bedrocan Cannabis was founded in Canada.
In 2024, Bedrocan Cannabis is currently focus on healthcare professionals sector.
Above is snippet of Google Trends for "healthcare professionals" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Bedrocan Cannabis, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
